During the past decade, Georgia Retina PC conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 13 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Retina PC" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Ionis Pharmaceuticals, Inc." with 4 trials sponsored, "Allergan" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "Gyroscope Therapeutics Limited" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Retina PC" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Milton S. Hershey Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Retina PC" are "Geographic Atrophy" (9 trials), "Diabetic Macular Edema" (7 trials), "Macular Degeneration" (5 trials), "Cytomegalovirus Retinitis" (4 trials) and "HIV Infections" (4 trials). Many other conditions were trialed in "Georgia Retina PC" in a lesser frequency.

Most popular intervention types in "Georgia Retina PC" are "Drug" (35 trials), "Other" (7 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Faricimab" (8 trials), "Aflibercept" (7 trials), "Fomivirsen sodium" (4 trials) and "Ranibizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Retina PC" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Retina PC". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Georgia Retina PC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Retina PC, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".